ENDOGEN ApS: Financial statements 2024
CVR: 29813337
Source: annual report 2024, Danish Business Authority
27/10/2023 – 26/10/2024
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -15,349 and a net result of DKK -22,939 compared with DKK -18,958 the year before. Equity in the 2024 report amounted to DKK -2,928. The company had 1 employee in the financial year.
- Gross Profit
- DKK -15,349
- Profit/Loss
- DKK -22,939
- Equity
- DKK -2,928
- Total Assets
- DKK 128,848
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -15 t. | -23 t. | -3 t. | 1 |
| 2023 | - | -19 t. | -19 t. | 20 t. | 1 |
| 2022 | - | -15 t. | -15 t. | 39 t. | 1 |
| 2021 | - | -23 t. | -24 t. | 54 t. | 1 |
| 2020 | - | -18 t. | -18 t. | 79 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ENDOGEN ApS has published its annual report for 2023. Gross profit came to DKK -18,958, and the net result was DKK -18,958.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.